Pharmacokinetics of (-)-epicatechin in rabbits

Yen An Chen, Kuang Yang Hsu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The aim of this study was to investigate the pharmacokinetics of (-)-epicatechin (EC) in rabbits after intravenous, intraperitoneal, and oral administration. A two-compartment model was used to describe the pharmacokinetics of EC after intravenous administration. EC showed dose-independent pharmacokinetics after intravenous administration. In addition, the area under the concentration-time curve was proportional to the dose over the range 5-25 mg/kg. After intraperitoneal administration of 25 mg/kg, a high percentage of EC escaped from first-pass hepatic elimination. After oral administration of 50 mg/kg, there was a great variation in the pharmacokinetics, and the mean oral bioavailability of EC was 4%. There was no significant difference in the elimination rate constants in all treatments (p>0.05). In conclusion, after intravenous, intraperitoneal, and oral administration of EC, the EC exhibits dose-independent pharmacokinetics in rabbits. The first-pass effect did not participate in the low oral bioavailability. Base on the results of the present study, the other factors may contribute the low oral bioavailability.

Original languageEnglish
Pages (from-to)149-154
Number of pages6
JournalArchives of Pharmacal Research
Volume32
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Pharmacokinetics
Catechin
Rabbits
Intravenous Administration
Biological Availability
Oral Administration
Rate constants

Keywords

  • (-)-Epicatechin
  • Bioavailability
  • Pharmacokinetics

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Organic Chemistry

Cite this

Pharmacokinetics of (-)-epicatechin in rabbits. / Chen, Yen An; Hsu, Kuang Yang.

In: Archives of Pharmacal Research, Vol. 32, No. 1, 01.2009, p. 149-154.

Research output: Contribution to journalArticle

Chen, Yen An ; Hsu, Kuang Yang. / Pharmacokinetics of (-)-epicatechin in rabbits. In: Archives of Pharmacal Research. 2009 ; Vol. 32, No. 1. pp. 149-154.
@article{ce007579a3074dafa948473363cdc3ac,
title = "Pharmacokinetics of (-)-epicatechin in rabbits",
abstract = "The aim of this study was to investigate the pharmacokinetics of (-)-epicatechin (EC) in rabbits after intravenous, intraperitoneal, and oral administration. A two-compartment model was used to describe the pharmacokinetics of EC after intravenous administration. EC showed dose-independent pharmacokinetics after intravenous administration. In addition, the area under the concentration-time curve was proportional to the dose over the range 5-25 mg/kg. After intraperitoneal administration of 25 mg/kg, a high percentage of EC escaped from first-pass hepatic elimination. After oral administration of 50 mg/kg, there was a great variation in the pharmacokinetics, and the mean oral bioavailability of EC was 4{\%}. There was no significant difference in the elimination rate constants in all treatments (p>0.05). In conclusion, after intravenous, intraperitoneal, and oral administration of EC, the EC exhibits dose-independent pharmacokinetics in rabbits. The first-pass effect did not participate in the low oral bioavailability. Base on the results of the present study, the other factors may contribute the low oral bioavailability.",
keywords = "(-)-Epicatechin, Bioavailability, Pharmacokinetics",
author = "Chen, {Yen An} and Hsu, {Kuang Yang}",
year = "2009",
month = "1",
doi = "10.1007/s12272-009-1129-x",
language = "English",
volume = "32",
pages = "149--154",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "1",

}

TY - JOUR

T1 - Pharmacokinetics of (-)-epicatechin in rabbits

AU - Chen, Yen An

AU - Hsu, Kuang Yang

PY - 2009/1

Y1 - 2009/1

N2 - The aim of this study was to investigate the pharmacokinetics of (-)-epicatechin (EC) in rabbits after intravenous, intraperitoneal, and oral administration. A two-compartment model was used to describe the pharmacokinetics of EC after intravenous administration. EC showed dose-independent pharmacokinetics after intravenous administration. In addition, the area under the concentration-time curve was proportional to the dose over the range 5-25 mg/kg. After intraperitoneal administration of 25 mg/kg, a high percentage of EC escaped from first-pass hepatic elimination. After oral administration of 50 mg/kg, there was a great variation in the pharmacokinetics, and the mean oral bioavailability of EC was 4%. There was no significant difference in the elimination rate constants in all treatments (p>0.05). In conclusion, after intravenous, intraperitoneal, and oral administration of EC, the EC exhibits dose-independent pharmacokinetics in rabbits. The first-pass effect did not participate in the low oral bioavailability. Base on the results of the present study, the other factors may contribute the low oral bioavailability.

AB - The aim of this study was to investigate the pharmacokinetics of (-)-epicatechin (EC) in rabbits after intravenous, intraperitoneal, and oral administration. A two-compartment model was used to describe the pharmacokinetics of EC after intravenous administration. EC showed dose-independent pharmacokinetics after intravenous administration. In addition, the area under the concentration-time curve was proportional to the dose over the range 5-25 mg/kg. After intraperitoneal administration of 25 mg/kg, a high percentage of EC escaped from first-pass hepatic elimination. After oral administration of 50 mg/kg, there was a great variation in the pharmacokinetics, and the mean oral bioavailability of EC was 4%. There was no significant difference in the elimination rate constants in all treatments (p>0.05). In conclusion, after intravenous, intraperitoneal, and oral administration of EC, the EC exhibits dose-independent pharmacokinetics in rabbits. The first-pass effect did not participate in the low oral bioavailability. Base on the results of the present study, the other factors may contribute the low oral bioavailability.

KW - (-)-Epicatechin

KW - Bioavailability

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=59449101050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59449101050&partnerID=8YFLogxK

U2 - 10.1007/s12272-009-1129-x

DO - 10.1007/s12272-009-1129-x

M3 - Article

VL - 32

SP - 149

EP - 154

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 1

ER -